The government has ordered state drug controllers not to allow companies to market drug formulations in which the composition has been tweaked, while retaining the old brand name.
Pharma cos can’t sell tweaked drugs under old brand name
More from Industry NewsMore posts in Industry News »
- India tops the chart for approved biosimilars and clinical trials surpassing USA and Europe: 10th Annual Pharma IPR India Conference
- India initiates antidumping probe on certain type of steel from Brazil, China, Germany
- BDR Pharma receives DGCI nod for its generic drug BIAPENEM
- AstraZeneca invests in Imperial’s self-amplifying RNA technology with eye on future drugs